Abstract
Retrograde intrabiliary infusion (RII) has recently been characterized as a safe and effective administration route for liver-targeted gene delivery. Efficient transgene expression in the liver has been achieved by infusing a variety of gene vectors including adenovirus, retrovirus, lipoplexes, polyplexes, and naked DNA through the common bile duct. Here, we describe the RII technique and key infusion parameters for delivering plasmid DNA and DNA nanoparticles to the rat liver. After RII of plasmid DNA, the level of transgene expression in rat liver is comparable to that achieved by hydrodynamic injection of plasmid DNA, which is considered to be “gold standard” for liver-targeted gene delivery. RII has also been shown to significantly enhance the gene delivery efficiency by polymer/DNA nanoparticles in comparison with intravenous and intraportal infusions. This method induces minimal level of cytotoxicity and damage to the liver and bile duct. Due to these advantages, RII has the potential to be used for delivering various gene vectors in clinical setting through the endoscopic retrograde cholangiopancreatography procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nguyen TH, Ferry N (2004) Liver gene therapy: advances and hurdles. Gene Ther 11:S76–S84
Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ (2002) Gene therapy as an alternative to liver transplantation. Liver Transpl 8:1089–1108
Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J (2003) The promise of gene therapy in gastrointestinal and liver diseases. Gut 52:ii49–ii54
Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo SLC (1993) Hepatic gene-therapy - efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA 90:11548–11552
Nathwani AC, Davidoff AM, Hanawa H, Hu YN, Hoffer FA, Nikanorov A, Slaughter C, Ng CYC, Zhou JF, Lozier JN, Mandrell TD, Vanin EF, Nienhuis AW (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 100:1662–1669
Cheung ST, Tsui TY, Wang WL, Yang ZF, Wong SY, Ip YC, Luk J, Fan ST (2002) Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol 17:1008–1014
Jooss K, Chirmule N (2003) Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 10:955–963
Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R, Grewe N, Schnieders F, Heeren J, Manns MP, Schlag PM, Strauss M (1999) Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1:360–371
Treco DA, Selden RF (1995) Nonviral gene-therapy. Mol Med Today 1:314–321
Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453–458
Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647–1652
Kawakami S, Yamashita F, Nishida K, Nakamura J, Hashida M (2002) Glycosylated cationic Liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 19:171–190
Rogers JV, Bigley NJ, Chiou HC, Hull BE (2000) Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge. Arch Dermatol Res 292:542–549
Reichen J (1999) The role of the sinusoidal endothelium in liver function. News Physiol Sci 14:117–121
Otsuka M, Baru M, Delriviere L, Talpe S, Nur I, Gianello P (2000) In vivo liver-directed gene transfer in rats and pigs with large anionic multilamellar liposomes: routes of administration and effects of surgical manipulations on transfection efficiency. J Drug Target 8:267–279
Zakim D, Boyer TD (2003) Hepatology: a textbook of liver disease. Saunders, Philadelphia
Ludwig J, Ritman EL, LaRusso NF, Sheedy PF, Zumpe G (1998) Anatomy of the human biliary system studied by quantitative computer-aided three-dimensional imaging techniques. Hepatology 27:893–899
Bircher J (1999) Oxford textbook of clinical hepatology. Oxford University Press, Oxford
Zhang XH, Collins L, Sawyer GJ, Dong XB, Qiu Y, Fabre JW (2001) In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine. Hum Gene Ther 12:2179–2190
Xie X, Forsmark CE, Lau JYN (1997) Feasibility of adenoviral-mediated gene delivery through ERCP - the effect or bile and pancreatic juice. Hepatology 26:276–276
Xie XM, Forsmark CE, Lau JYN (2000) Effect of bile and pancreatic juice on adenoviral-mediated gene delivery - implications on the feasibility of gene delivery through ERCP. Dig Dis Sci 45:230–236
Tominaga K, Kuriyama S, Yoshiji H, Deguchi A, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Tsujimoto T, Fukui H (2004) Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies. Gut 53:1167–1173
Dai H, Jiang X, Tan GC, Chen Y, Torbenson M, Leong KW, Mao HQ (2006) Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomedicine 1:507–522
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Jiang, X., Ren, Y., Williford, JM., Li, Z., Mao, HQ. (2013). Liver-Targeted Gene Delivery Through Retrograde Intrabiliary Infusion. In: Ogris, M., Oupicky, D. (eds) Nanotechnology for Nucleic Acid Delivery. Methods in Molecular Biology, vol 948. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-140-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-62703-140-0_19
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-139-4
Online ISBN: 978-1-62703-140-0
eBook Packages: Springer Protocols